{
    "clinical_study": {
        "@rank": "43553", 
        "arm_group": [
            {
                "arm_group_label": "Hand-written diary first", 
                "arm_group_type": "Other", 
                "description": "Participants in this group will use the hand-written diary for the first two week and switch to Kinesia HomeView and the electronic diary for the second two weeks."
            }, 
            {
                "arm_group_label": "Kinesia HomeView first", 
                "arm_group_type": "Other", 
                "description": "Participants in this group will use Kinesia HomeView and the electronic diary for the first two week and switch to the hand-written diary for the second two weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective is to compare the sensitivity and test-retest reliability of Kinesia HomeView\n      to electronic and hand-written diaries for tracking medication state in the home.\n      Demonstrating comparable or superior results will further support use of the Kinesia\n      HomeView system as an outcome measure in clinical drug trials."
        }, 
        "brief_title": "Kinesia HomeView - Home Diary Comparison", 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of Parkinson's disease\n\n          -  On a stable antiparkinsonian medication regimen that includes levodopa for at least 4\n             weeks\n\n          -  Experiencing dyskinesia more than 25% of the waking day (score \u2265 2 on Unified\n             Parkinson's Disease Rating Scale item 32)\n\n          -  With dyskinesias at least moderately disabling (score \u2265 2 on Unified Parkinson's\n             Disease Rating Scale item 33)\n\n          -  Capable of accurately completing diaries\n\n          -  Capable of accurately using Kinesia HomeView\n\n        Exclusion Criteria:\n\n          -  Significant medical or psychiatric illness\n\n          -  Subjects not capable of following the required clinical instructions\n\n          -  Serious medical conditions that would compromise safety"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01920425", 
            "org_study_id": "1311DH", 
            "secondary_id": "1311DH"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Hand-written diary first", 
                    "Kinesia HomeView first"
                ], 
                "description": "Motion sensor based telemedicine system for assessment of movement disorder motor symptoms in the home. Includes automated motor assessment using motion sensor and electronic dyskinesia diary.", 
                "intervention_name": "Kinesia HomeView", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Hand-written diary first", 
                    "Kinesia HomeView first"
                ], 
                "description": "Hand-written paper diary indicating state (Off, On without dyskinesias, on with non-troublesome dyskinesias, on with troublesome dyskinesias) at 30 minute intervals.", 
                "intervention_name": "Hand-written diary", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Parkinson's disease", 
            "dyskinesia", 
            "fluctuations", 
            "tremor", 
            "bradykinesia", 
            "levodopa"
        ], 
        "lastchanged_date": "February 20, 2014", 
        "location": {
            "contact": {
                "email": "cpulliam@glneurotech.com", 
                "last_name": "Chris Pulliam, PhD", 
                "phone": "216-446-2452"
            }, 
            "contact_backup": {
                "email": "dheldman@glneurotech.com", 
                "last_name": "Dustin Heldman, PhD", 
                "phone": "216-446-2437"
            }, 
            "facility": {
                "address": {
                    "city": "Valley View", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44125"
                }, 
                "name": "Great Lakes NeuroTechnologies Inc"
            }, 
            "investigator": {
                "last_name": "Dustin A Heldman, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Kinesia HomeView - Home Diary Comparison", 
        "overall_contact": {
            "email": "cpulliam@glneurotech.com", 
            "last_name": "Chirs Pulliam, PhD", 
            "phone": "216-446-2452"
        }, 
        "overall_contact_backup": {
            "email": "dheldman@glneurotech.com", 
            "last_name": "Dustin Heldman, PhD", 
            "phone": "216-446-2437"
        }, 
        "overall_official": {
            "affiliation": "Great Lakes NeuroTechnologies Inc.", 
            "last_name": "Dustin A Heldman, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Test-retest reliability will be compared between Kinesia HomeView measures, hand-written diary entries, and electronic diary entries.", 
            "measure": "Test-retest reliability", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01920425"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Questionnaires on the usability of Kinesia HomeView will be completed following the 4-week data collection period.", 
            "measure": "Kinesia HomeView usability questionnaire", 
            "safety_issue": "No", 
            "time_frame": "After 4 weeks"
        }, 
        "source": "Great Lakes NeuroTechnologies Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Great Lakes NeuroTechnologies Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}